Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition
Open accessAbstract
It is necessary to understand mechanisms by which differentiating agents influence tumor-initiating cancer stem cells. Toward this end, we investigated the cellular and molecular responses of glioblastoma stem-like cells (GBM-SCs) to all-trans retinoic acid (RA). GBM-SCs were grown as non-adherent neurospheres in growth factor supplemented serum-free medium. RA treatment rapidly induced morphology changes, induced growth arrest at G1/G0 to S transition, decreased cyclin D1 expression and increased p27 expression. Immunofluorescence and western blot analysis indicated that RA induced the expression of lineage-specific differentiation markers Tuj1 and GFAP and reduced the expression of neural stem cell markers such as CD133, Msi-1, nestin and Sox-2. RA treatment dramatically decreased neurosphere-forming capacity, inhibited the ability of neurospheres to form colonies in soft agar and inhibited their capacity to propagate subcutaneous and intracranial xenografts. Expression microarray analysis identified ∼350 genes that were altered within 48 h of RA treatment. Affected pathways included retinoid signaling and metabolism, cell-cycle regulation, lineage determination, cell adhesion, cell-matrix interaction and cytoskeleton remodeling. Notch signaling was the most prominent of these RA-responsive pathways. Notch pathway downregulation was confirmed based on the downregulation of HES and HEY family members. Constitutive activation of Notch signaling with the Notch intracellular domain rescued GBM neurospheres from the RA-induced differentiation and stem cell depletion. Our findings identify mechanisms by which RA targets GBM-derived stem-like tumor-initiating cells and novel targets applicable to differentiation therapies for glioblastoma.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ATRA inhibits proliferation of glioblastoma cells in vitro and in vivo, while promoting their differentiation.
“ATRA inhibits proliferation of glioblastoma cells in vitro and in vivo, while promoting their differentiation117,118.”
From Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine (2020) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.76.9.4350 · Cited by 51,421 · see citing works
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610 · see citing works
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., TAPHOORN, M. J. B., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Bélanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,667 · see citing works
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,388 · see citing works
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,363 · see citing works
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., Vitis, S. D., Fiocco, R., Foroni, C., DiMeco, F., & Vescovi, A. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570 · see citing works
Lee, J., Kotliarova, S. E., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,289 · see citing works
Notch Promotes Radioresistance of Glioma Stem Cells
Wang, J., Wakeman, T. P., Lathia, J. D., Hjelmeland, A. B., Wang, X.-F., White, R. R., Rich, J. N., & Sullenger, B. A. (2009) · Stem Cells · doi:10.1002/stem.261 · Cited by 657 · see citing works
Fan, X., Khaki, L., Zhu, T. S., Soules, M. E., Talsma, C. E., Gul, N., Koh, C. M., Zhang, J., Li, Y., Maciaczyk, J., et al. (2009) · Stem Cells · doi:10.1002/stem.254 · Cited by 646 · see citing works
Stem cell origin of cancer and differentiation therapy
Sell, S. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.04.007 · Cited by 638 · see citing works
Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like Cancer Cells in Glioblastoma
Bar, E. E., Chaudhry, A., Lin, A. Y., Fan, X., Schreck, K. C., Matsui, W. H., Piccirillo, S. G. M., Vescovi, A. L., DiMeco, F., Olivi, A., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0166 · Cited by 605 · see citing works
Mark, M. P., Ghyselinck, N. B., & Chambon, P. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141156 · Cited by 596 · see citing works
Retinoids, Retinoic Acid Receptors, and Cancer
Tang, X.-H., & Gudas, L. J. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130303 · Cited by 596 · see citing works
Therapeutic implications of cancer stem cells
Al‐Hajj, M., Becker, M. W., Wicha, M. S., Weissman, I. L., & Clarke, M. F. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.007 · Cited by 561 · see citing works
Vescovi, A. L., Parati, E. A., Gritti, A., Poulin, P., Ferrario, M., Wanke, E., Frolichsthal, P., Cova, L., Arcellana‐Panlilio, M. Y., Colombo, A., et al. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6998 · Cited by 558 · see citing works
Wang, W., Osenbroch, P. Ø., Skinnes, R., Esbensen, Y., Bjørås, M., & Eide, L. (2010) · Stem Cells · doi:10.1002/stem.542 · Cited by 243 · see citing works
Multiple functions of Notch signaling in self‐renewing organs and cancer
Wilson, A., & Radtke, F. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.024 · Cited by 217 · see citing works
Retinoid signaling regulates breast cancer stem cell differentiation
Ginestier, C., Wicinski, J., Cervera, N., Monville, F., Finetti, P., Bertucci, F., Wicha, M. S., Birnbaum, D., & Charafe‐Jauffret, E. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9761 · Cited by 217 · see citing works
Notch Signaling Enhances Nestin Expression in Gliomas
Shih, A. H., & Holland, E. C. (2006) · Neoplasia · doi:10.1593/neo.06526 · Cited by 204 · see citing works
Shi, Y., Sun, G., Zhao, C., & Stewart, R. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.06.004 · Cited by 188 · see citing works
Diverse actions of retinoid receptors in cancer prevention and treatment
Mongan, N. P., & Gudas, L. J. (2007) · Differentiation · doi:10.1111/j.1432-0436.2007.00206.x · Cited by 182 · see citing works
Tumour stem cell-targeted treatment: elimination or differentiation
Massard, C., Deutsch, É., & Soria, J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl074 · Cited by 177 · see citing works
Differential properties of adult rat and mouse brain-derived neural stem/progenitor cells
Ray, J., & Gage, F. H. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.11.010 · Cited by 172 · see citing works
Role of Retinoic Acid in the Differentiation of Embryonal Carcinoma and Embryonic Stem Cells
Soprano, D. R., Teets, B. W., & Soprano, K. J. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(06)75003-8 · Cited by 153 · see citing works
Dynamic regulation of Notch signaling in neural progenitor cells
Kageyama, R., Ohtsuka, T., Shimojo, H., & Imayoshi, I. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.08.009 · Cited by 150 · see citing works
Jaeckle, K. A., Hess, K. R., Yung, W. K. A., Greenberg, H. S., Fine, H. A., Schiff, D., Pollack, I. F., Kuhn, J. G., Fink, K., Mehta, M. P., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.097 · Cited by 149 · see citing works
Tenascin-C Is a Novel RBPJκ-Induced Target Gene for Notch Signaling in Gliomas
Sivasankaran, B., Degen, M., Ghaffari, A., Hegi, M. E., Hamou, M., Ionescu, M.-C. S., Zweifel, C., Tolnay, M., Wasner, M., Mergenthaler, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2610 · Cited by 143 · see citing works
Signaling pathways in retinoid chemoprevention and treatment of cancer
Niles, R. M. (2004) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.05.020 · Cited by 141 · see citing works
DNA repair and cancer stem-like cells – Potential partners in glioma drug resistance?
Johannessen, T.-C. A., Bjerkvig, R., & Tysnes, B. B. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.03.125 · Cited by 132 · see citing works
Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.
Yung, W. K. A., Kyritsis, A. P., Gleason, M. J., & Levin, V. A. (1996) · PubMed · Cited by 122 · see citing works
Targeting the c-Met Pathway Potentiates Glioblastoma Responses to γ-Radiation
Lal, B., Xia, S., Abounader, R., & Laterra, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0166 · Cited by 120 · see citing works
Self-citationYu, X., Zou, J., Ye, Z., Hammond, H., Chen, G., Tokunaga, A., Mali, P., Li, Y. M., Civin, C. I., Gaiano, N., et al. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.03.001 · Cited by 116 · see citing works
WALSH, J., & Andrews, P. W. (2003) · Apmis · doi:10.1034/j.1600-0463.2003.1110124.x · Cited by 99 · see citing works
Sun, P., Xia, S., Lal, B., Eberhart, C. G., Quiñones‐Hinojosa, A., Maciaczyk, J., Matsui, W. H., DiMeco, F., Piccirillo, S. G. M., Vescovi, A. L., et al. (2009) · Stem Cells · doi:10.1002/stem.89 · Cited by 96 · see citing works
Self-citationTherapy-induced PML/RARA Proteolysis and Acute Promyelocytic Leukemia Cure
Nasr, R., Lallemand-Breitenbach, V., Zhu, J., Guillemin, M.-C., & de Thé, H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0209 · Cited by 96 · see citing works
Transcription-Dependent Epidermal Growth Factor Receptor Activation by Hepatocyte Growth Factor
Reznik, T. E., Sang, Y., Ma, Y., Abounader, R., Rosen, E. M., Xia, S., & Laterra, J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0236 · Cited by 94 · see citing works
Self-citationCancer Stem Cells and Differentiation Therapy
Sell, S. (2006) · Tumor Biology · doi:10.1159/000092323 · Cited by 92 · see citing works
Karmakar, S., Banik, N. L., & Ray, S. K. (2007) · Cancer · doi:10.1002/cncr.23223 · Cited by 92 · see citing works
PPARγ agonists inhibit growth and expansion of CD133+ brain tumour stem cells
Chearwae, W., & Bright, J. J. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604786 · Cited by 90 · see citing works
13-cis-Retinoic acid in the treatment of recurrent glioblastoma multiforme
See, S.-J., Levin, V. A., Yung, W.-K. A., Hess, K. R., & Groves, M. D. (2004) · Neuro-Oncology · doi:10.1215/s1152851703000607 · Cited by 69 · see citing works
Diagnosis and treatment of acute promyelocytic leukemia
Jurcic, J. G., Soignet, S. L., & Maslak, P. G. (2007) · Current Oncology Reports · doi:10.1007/s11912-007-0045-9 · Cited by 52 · see citing works
Retinoid Targets in Cancer Therapy and Chemoprevention
Dragnev, K. H., Petty, J., & Dmitrovsky, E. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.215 · Cited by 52 · see citing works
Butowski, N. A., Prados, M. D., Lamborn, K. R., Larson, D. A., Sneed, P. K., Wara, W. M., Malec, M. K., Rabbitt, J. E., Page, M., & Chang, S. M. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.08.023 · Cited by 50 · see citing works
Cyr61 Mediates Hepatocyte Growth Factor–Dependent Tumor Cell Growth, Migration, and Akt Activation
Goodwin, C. R., Lal, B., Zhou, X., Ho, S., Xia, S., Taeger, A., Murray, J., & Laterra, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3570 · Cited by 48 · see citing works
Self-citationDas, A., Banik, N. L., & Ray, S. K. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9485-1 · Cited by 46 · see citing works
Global gene expression patterns during neural differentiation of P19 embryonic carcinoma cells
Wei, Y., Harris, T., & Childs, G. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700409.x · Cited by 43 · see citing works
Brain tumour stem cells: possibilities of new therapeutic strategies
Piccirillo, S. G. M., & Vescovi, A. L. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.8.1129 · Cited by 42 · see citing works
Radioresistant glioma stem cells—Therapeutic obstacle or promising target?
Chalmers, A. J. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.03.019 · Cited by 40 · see citing works
Zhang, R., Banik, N. L., & Ray, S. K. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9417-7 · Cited by 39 · see citing works
Harris, T. M., & Childs, G. J. (2002) · Functional & Integrative Genomics · doi:10.1007/s10142-002-0062-6 · Cited by 34 · see citing works
Sangster‐Guity, N., Yu, L., & McCormick, P. J. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.11.1190 · Cited by 33 · see citing works
An, J., Yuan, Q., Wang, C., Liu, L., Tang, K., Tian, H.-Y., Jing, N.-H., & Zhao, F. (2005) · PROTEOMICS · doi:10.1002/pmic.200401049 · Cited by 30 · see citing works
Applications of emerging molecular technologies in glioblastoma multiforme
Kumar, H. R., Zhong, X., Sandoval, J. A., Hickey, R. J., & Malkas, L. H. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.10.1497 · Cited by 26 · see citing works
ES cell neural differentiation reveals a substantial number of novel ESTs
Bain, G., Mansergh, F. C., Wride, M. A., Hance, J., Isogawa, A., Rancourt, S. L., Ray, W. J., Yoshimura, Y., Tsuzuki, T., Gottlieb, D. I., et al. (2000) · Functional & Integrative Genomics · doi:10.1007/s101420000014 · Cited by 23 · see citing works
Murata-Ohsawa, M., Tohda, S., Kogoshi, H., Sakano, S., & Nara, N. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.05.020 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Aldehyde dehydrogenase 1A1 in stem cells and cancer
Tomita, H., Tanaka, K. Y., Tanaka, T., & Hara, A. (2016) · Oncotarget · doi:10.18632/oncotarget.6920 · Cited by 597 · see citing works
Cancer stem cells and chemoresistance: The smartest survives the raid
Zhao, J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.02.008 · Cited by 433 · see citing works
Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells
Vassalli, G. (2019) · Stem Cells International · doi:10.1155/2019/3904645 · Cited by 291 · see citing works
Retinoic acid signaling and neuronal differentiation
Janesick, A., Wu, S. C., & Blumberg, B. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1815-9 · Cited by 295 · see citing works
Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets
Clark, D. W., & Palle, K. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.11.82 · Cited by 227 · see citing works
Cancer stem cells: In the line of fire
Alison, M. R., Lin, W., Lim, S. M. L., & Nicholson, L. J. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.03.003 · Cited by 222 · see citing works
Modulation of T Cell and Innate Immune Responses by Retinoic Acid
Raverdeau, M., & Mills, K. H. G. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303245 · Cited by 222 · see citing works
Binda, E., Visioli, A., Giani, F., Lamorte, G., Copetti, M., Pitter, K. L., Huse, J. T., Cajola, L., Zanetti, N., DiMeco, F., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.11.005 · Cited by 217 · see citing works
Connolly, R. M., Nguyen, N. K., & Sukumar, S. V. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3175 · Cited by 211 · see citing works
Liu, Y., Yang, C., Huang, M.-S., Yeh, C., Wu, A. T. H., Lee, Y., Lai, T., Lee, C.-H., Hsiao, Y.-W., Lu, J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1733 · Cited by 210 · see citing works
Aldehyde dehydrogenases and cancer stem cells
Xu, X., Chai, S., Wang, P., Zhang, C., Yang, Y., Yang, Y., & Wang, K. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.08.018 · Cited by 205 · see citing works
Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells
Wang, B., Wang, Q., Wang, Z., Jiang, J., Yu, S., Ping, Y., Yang, J., Xu, S., Ye, X.-Z., Xu, C. S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2563 · Cited by 198 · see citing works
Role of Notch Signaling Pathway in Glioblastoma Pathogenesis
Bazzoni, R., & Bentivegna, A. (2019) · Cancers · doi:10.3390/cancers11030292 · Cited by 192 · see citing works
Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation
Huang, S., Wang, L.-L., Xue, N., Li, C., Guo, H., Ren, T., Zhan, Y., Li, W., Zhang, J., Chen, X., et al. (2019) · Theranostics · doi:10.7150/thno.34674 · Cited by 189 · see citing works
Wang, J., Zibetti, C., Shang, P., Sripathi, S. R., Zhang, P., Cano, M., Hoang, T., Xia, S., Ji, H., Merbs, S. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03856-y · Cited by 185 · see citing works
Self-citationAlves, A. L. V., Gomes, I. N. F., Carloni, A. C., Rosa, M. N., da Silva, L. S., Evangelista, A. F., Reis, R. M., & Silva, V. A. O. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02231-x · Cited by 186 · see citing works
Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation
Berezovsky, A. D., Poisson, L., Cherba, D., Webb, C. P., Transou, A. D., Lemke, N. W., Hong, X., Hasselbach, L. A., Irtenkauf, S. M., Mikkelsen, T., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.03.006 · Cited by 167 · see citing works
ALDH as a Stem Cell Marker in Solid Tumors
Toledo-Guzmán, M. E., Ibáñez-Hernández, M. Á., Gallegos, A. A. G., & Ortíz-Sánchez, E. (2018) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x13666180810120012 · Cited by 150 · see citing works
Glioblastoma: Pathogenesis and Current Status of Chemotherapy and Other Novel Treatments
Rajaratnam, V., Islam, M. M., Yang, M., Slaby, R., Ramirez, H. M., & Mirza, S. P. (2020) · Cancers · doi:10.3390/cancers12040937 · Cited by 147 · see citing works
Xia, S., Lal, B., Tung, B., Wang, S., Goodwin, C. R., & Laterra, J. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov171 · Cited by 143 · see citing works
Self-citationNguyen, P. H., Giraud, J., Staedel, C., Chambonnier, L., Dubus, P. R., Chevret, E., Bœuf, H., Gauthereau, X., Rousseau, B., Fevre, M., et al. (2016) · Oncogene · doi:10.1038/onc.2016.87 · Cited by 143 · see citing works
Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems
Dianat-Moghadam, H., Heidarifard, M., Jahanban-Esfahlan, R., Panahi, Y., Hamishehkar, H., Pouremamali, F., Rahbarghazi, R., & Nouri, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.043 · Cited by 140 · see citing works
Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III
Emlet, D. R., Gupta, P. K., Holgado-Madruga, M., Fitz, C. D. V., Mitra, S. S., Han, S., Li, G., Jensen, K. C., Vogel, H. S., Xu, L. W., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1407 · Cited by 138 · see citing works
Chen, Y., Wang, X., Zhang, Q., Zhu, J., Li, Y., Xie, C., Li, X., Wu, J., Geng, S., Zhong, C., et al. (2017) · Nutrients · doi:10.3390/nu9060572 · Cited by 139 · see citing works
Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine
Ferreira, R., Napoli, J., Enver, T., Bernardino, L., & Ferreira, L. (2020) · Nature Communications · doi:10.1038/s41467-020-18042-2 · Cited by 138 · see citing works
HMMR Maintains the Stemness and Tumorigenicity of Glioblastoma Stem-like Cells
Tilghman, J. I., Wu, H., Sang, Y., Shi, X., Guerrero‐Cazares, H., Quiñones‐Hinojosa, A., Eberhart, C. G., Laterra, J., & Ying, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2103 · Cited by 134 · see citing works
Self-citationKim, D., Choi, B.-H., Ryoo, I.-G., & Kwak, M. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0903-4 · Cited by 126 · see citing works
Li, H., & Yang, B. B. (2012) · Oncotarget · doi:10.18632/oncotarget.810 · Cited by 117 · see citing works
Liu, Y., Zheng, J., Zhang, Y., Wang, Z., Yang, Y., Bai, M., & Dai, Y. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1989-7 · Cited by 114 · see citing works
Kozielski, K., Ruiz‐Valls, A., Tzeng, S. Y., Guerrero‐Cazares, H., Rui, Y., Li, Y., Vaughan, H. J., Gionet‐Gonzales, M., Vantucci, C. E., Kim, J., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.020 · Cited by 110 · see citing works
Self-citationLim, Y. C., Kang, H. J., Kim, Y. S., & Choi, E. C. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.04.013 · Cited by 109 · see citing works
Oncolytic measles virus strains have significant antitumor activity against glioma stem cells
Allen, C., Opyrchal, M., Aderca, I., Schroeder, M. A., Sarkaria, J. N., Domingo‐Musibay, E., Federspiel, M. J., & Galanis, E. (2012) · Gene Therapy · doi:10.1038/gt.2012.62 · Cited by 107 · see citing works
Retinoic acid and cancer treatment
Chen, M.-C., Hsu, S.-L., Lin, H., & Yang, T.-Y. (2014) · BioMedicine · doi:10.7603/s40681-014-0022-1 · Cited by 105 · see citing works
Chemical approaches to targeting drug resistance in cancer stem cells
Sotiropoulou, P. A., Christodoulou, M. S., Silvani, A., Herold-Mende, C., & Passarella, D. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.05.002 · Cited by 100 · see citing works
HONG, X., Chedid, K., & Kalkanis, S. N. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1592 · Cited by 101 · see citing works
A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics
Lv, D., Yu, S., Ping, Y., Wu, H., Zhao, X., Zhang, H., Cui, Y., Chen, B., Zhang, X., Dai, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10885 · Cited by 96 · see citing works
Sd, W., Rath, P., Lal, B., Richard, J.-P., Li, Y., Goodwin, C. R., Laterra, J., & Xia, S. (2012) · Oncogene · doi:10.1038/onc.2012.16 · Cited by 95 · see citing works
Self-citationControl of glioma cell death and differentiation by PKM2–Oct4 interaction
Morfouace, M., Lalier-Bretaudeau, L., Oliver, L., Cheray, M., Pecqueur, C., Cartron, P., & Vallette, F. M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.561 · Cited by 90 · see citing works
Ciechomska, I. A., Przanowski, P., Jackl, J., Wojtaś, B., & Kaminska, B. (2016) · Scientific Reports · doi:10.1038/srep38723 · Cited by 86 · see citing works
Aldehyde dehydrogenase 1A1 and 1A3 isoforms – mechanism of activation and regulation in cancer
Poturnajova, M., Kozovská, Z., & Matúšková, M. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110120 · Cited by 86 · see citing works
The strategies to cure cancer patients by eradicating cancer stem-like cells
Mai, Y., Su, J., Yang, C., Xia, C., & Fu, L. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01867-y · Cited by 78 · see citing works
Stacking the DEK: From chromatin topology to cancer stem cells
Vinnedge, L. M. P., Kappes, F., Nassar, N. N., & Wells, S. I. (2012) · Cell Cycle · doi:10.4161/cc.23121 · Cited by 70 · see citing works
Zhao, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i1.112 · Cited by 69 · see citing works
Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1
Bageritz, J., Puccio, L., Piro, R. M., Hovestadt, V., Phillips, E. S., Pankert, T., Lohr, J., Herold‐Mende, C. C., Lichter, P., & Goidts, V. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.12 · Cited by 69 · see citing works
Chitosan-Based Non-viral Gene and Drug Delivery Systems for Brain Cancer
Lara-Velazquez, M. A., Al‐kharboosh, R., Norton, E. S., Ramírez-Loera, C., Freeman, W. D., Guerrero‐Cazares, H., Forte, A. J., Quiñones‐Hinojosa, A., & Sarabia-Estrada, R. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00740 · Cited by 66 · see citing works
Self-citationChen, T., Chen, J., Zhu, Y., Li, Y., Wang, Y., Chen, H., Wang, J., Li, X., Liu, Y., Li, B., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0515-6 · Cited by 64 · see citing works
Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells
Oh, J., Hlatky, L., Jeong, Y., & Kim, D.-H. (2016) · Toxins · doi:10.3390/toxins8070199 · Cited by 60 · see citing works
Methylated cis-regulatory elements mediate KLF4-dependent gene transactivation and cell migration
Wan, J., Su, Y., Song, Q., Tung, B., Oyinlade, O., Liu, S., Ying, M., Ming, G., Song, H., Qian, J. X., et al. (2017) · eLife · doi:10.7554/elife.20068 · Cited by 56 · see citing works
Self-citationCruz, M. H., Sidén, Å., Calaf, G. M., Delwar, Z. M., & Yakisich, J. S. (2012) · ISRN Oncology · doi:10.5402/2012/392647 · Cited by 54 · see citing works
Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity
Sun, P., Xia, S., Lal, B., Shi, X., Yang, K. S., Watkins, P. A., & Laterra, J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-401 · Cited by 54 · see citing works
Self-citationNovel Therapies in Glioblastoma
Perry, J., Okamoto, M., Guiou, M., Shirai, K., Errett, A., & Chakravarti, A. (2012) · Neurology Research International · doi:10.1155/2012/428565 · Cited by 53 · see citing works
Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research
Son, B., Lee, W., Kim, H., Shin, H., & Park, H. H. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07077-8 · Cited by 52 · see citing works
Hu, P.-S., Xia, Q.-S., Wu, F., Li, D.-K., Qi, Y.-J., Hu, Y., Wei, Z.-Z., Ss, L., Tian, N.-Y., Qf, W., et al. (2017) · Oncogene · doi:10.1038/onc.2017.34 · Cited by 51 · see citing works
Characterization of mammary cancer stem cells in the MMTV-PyMT mouse model
Ma, J., Lanza, D. G., Guest, I., Uk-Lim, C., Glinskii, A. B., Glinsky, G. V., & Sell, S. (2012) · Tumor Biology · doi:10.1007/s13277-012-0458-4 · Cited by 49 · see citing works
Tenascin-C Function in Glioma: Immunomodulation and Beyond
Yalçın, F., Dzaye, O. D. A., & Xia, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-48457-6_9 · Cited by 50 · see citing works
Self-citationMia, M. A. R., Dey, D., Sakib, M. R., Biswas, M. Y., Prottay, A. A. S., Paul, N., Rimti, F. H., Abdullah, Y., Biswas, P., Iftehimul, M., et al. (2023) · Phytotherapy Research · doi:10.1002/ptr.8017 · Cited by 49 · see citing works
Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms
Cruceru, M. L., Neagu, M. T., Demoulin, J., & Constantinescu, S. N. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12122 · Cited by 48 · see citing works
Shingu, T., Holmes, L., Henry, V. K., Wang, Q., Latha, K., Gururaj, A. E., Gibson, L. A., Doucette, T. A., Lang, F. F., Rao, G., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0803-2 · Cited by 47 · see citing works
Impact of Chaperone-Mediated Autophagy in Brain Aging: Neurodegenerative Diseases and Glioblastoma
Auzmendi-Iriarte, J., & Matheu, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.630743 · Cited by 45 · see citing works
Lü, Z., Li, Y., Shi, Y., Li, Y., Xiao, Z., & Zhang, X. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703967 · Cited by 43 · see citing works
Wang, S., Shi, X., Wei, S., Ma, D., Oyinlade, O., Lv, S.-Q., Ying, M., Zhang, Y. A., Claypool, S. M., Watkins, P. A., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001323 · Cited by 43 · see citing works
Self-citationParker, D. J., Iyer, A. P., Shah, S., Moran, A., Hjelmeland, A. B., Basu, M. K., Liu, R., & Mitra, K. (2015) · Journal of Cell Science · doi:10.1242/jcs.172429 · Cited by 42 · see citing works
Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme
Gersey, Z. C., Osiason, A. D., Bloom, L., Shah, S. S., Thompson, J. W., Bregy, A., Agarwal, N., & Komotar, R. J. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.07.180 · Cited by 41 · see citing works
Disparate roles of retinoid acid signaling molecules in kidney disease
Chen, A., Liu, Y., Lu, Y., Lee, K., & He, C. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00045.2021 · Cited by 38 · see citing works
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells
Koyama‐Nasu, R., Haruta, R., Nasu‐Nishimura, Y., Taniue, K., KATOU, Y., Shirahige, K., Todo, T., Ino, Y., Mukasa, A., Saito, N., et al. (2013) · Oncogene · doi:10.1038/onc.2013.168 · Cited by 37 · see citing works
Wei, S., Wang, J., Oyinlade, O., Ma, D., Wang, S., Kratz, L. E., Lal, B., Xu, Q., Liu, S., Shah, S. R., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0334-9 · Cited by 38 · see citing works
Self-citationYan, Y.-H., Li, S.-H., Gao, Z., Zou, S.-F., Li, H.-Y., Tao, Z.-Y., Song, J., & Yang, J.-X. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.10.004 · Cited by 38 · see citing works
Stockhausen, M., Kristoffersen, K., Stobbe, L., & Poulsen, H. S. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.26736 · Cited by 36 · see citing works
Spina, R., Mills, I., Ahmad, F., Chen, C., Ames, H. M., Winkles, J. A., Woodworth, G. F., & Bar, E. E. (2022) · Oncogene · doi:10.1038/s41388-022-02517-1 · Cited by 35 · see citing works
Garcia, C. A., Bhargav, A. G., Brooks, M., Suárez-Meade, P., Mondal, S. K., Zarco, N., ReFaey, K., Jentoft, M. E., Middlebrooks, E. H., Snuderl, M., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0547 · Cited by 33 · see citing works
Self-citationBeijer, M. R., Molenaar, R., Goverse, G., Mebius, R. E., Kraal, G., & den Haan, J. M. M. (2013) · European Journal of Immunology · doi:10.1002/eji.201343325 · Cited by 33 · see citing works
The hidden architects of glioblastoma multiforme: Glioma stem cells
Sahoo, O. S., Mitra, R., & Nagaiah, N. K. H. (2024) · MedComm – Oncology · doi:10.1002/mog2.66 · Cited by 33 · see citing works
Inhibition of Glioma Development by ASCL1-Mediated Direct Neuronal Reprogramming
Cheng, X.-Y., Tan, Z., Huang, X., Yuan, Y., Qin, S., Gu, Y., Wang, D., He, C., & Su, Z. (2019) · Cells · doi:10.3390/cells8060571 · Cited by 31 · see citing works
ADAM17 regulates self-renewal and differentiation of U87 glioblastoma stem cells
Chen, X., Chen, L., Zhang, R., Yi, Y., Ma, Y., Yan, K., Jiang, X., & Wang, X. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.01.021 · Cited by 31 · see citing works
Therapeutic Targeting of Cancer Stem Cells
Maugeri‐Saccà, M., Zeuner, A., & Maria, R. D. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00010 · Cited by 31 · see citing works
Russo, I., Caroppo, F., & Alaibac, M. (2015) · Cancers · doi:10.3390/cancers7030841 · Cited by 29 · see citing works
Xanthis, V., Mantso, T., Dimtsi, A., Pappa, A., & Fadouloglou, V. E. (2023) · Cancers · doi:10.3390/cancers15174419 · Cited by 33 · see citing works
Multi‐echo Length and Offset VARied Saturation (MeLOVARS) method for improved CEST imaging
Song, X., Xu, J., Xia, S., Yadav, N. N., Lal, B., Laterra, J., Bulte, J. W. M., van Zijl, P. C. M., & McMahon, M. T. (2014) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25567 · Cited by 29 · see citing works
Self-citationAt the crossroads of cancer stem cells and targeted therapy resistance
Wang, A., Qu, L., & Wang, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.039 · Cited by 29 · see citing works
Patrad, E., Niapour, A., Farassati, F., & Amani, M. (2018) · Cytotechnology · doi:10.1007/s10616-018-0199-3 · Cited by 29 · see citing works
CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy
Hara, A., Koyama‐Nasu, R., Takami, M., Toyoda, T., Aoki, T., Ihara, F., Kobayashi, M., Hirono, S., Matsutani, T., Nakayama, T., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02742-1 · Cited by 29 · see citing works
Riddick, G., Kotliarova, S. E., Rodriguez, V., Kim, H., Linkous, A. G., Storaska, A. J., Ahn, S. J., Walling, J., Belova, G. I., & Fine, H. A. (2017) · Scientific Reports · doi:10.1038/srep43605 · Cited by 28 · see citing works
Tung, B., Ma, D., Wang, S., Oyinlade, O., Laterra, J., Ying, M., Lv, S.-Q., Wei, S., & Xia, S. (2018) · BMC Cancer · doi:10.1186/s12885-018-4874-8 · Cited by 28 · see citing works
Self-citationALDEFLUOR activity, ALDH isoforms, and their clinical significance in cancers
Duan, J., Cai, J., Gao, L., & Yu, S. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2023.2166035 · Cited by 28 · see citing works
Bie, C., Liang, Y., Zhang, L., Zhao, Y., Chen, Y., Zhang, X., He, X., & Song, X. (2019) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2019.09.14 · Cited by 27 · see citing works
Krawczynski, K., Godlewski, J. A., & Bronisz, A. (2020) · Antioxidants · doi:10.3390/antiox9080747 · Cited by 27 · see citing works
He, B.-C. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1426 · Cited by 27 · see citing works
Wang, Z., Xie, J., Yan, M., Wang, J., Wang, X., Zhang, J., Zhang, Y., Li, P., Lei, X., Huang, Q., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8503 · Cited by 25 · see citing works
Chen, T., Zhang, F., Liu, J., Huang, Z., Zheng, Y., Deng, S., Liu, Y., Wang, J., & Sun, X. (2021) · Oncogene · doi:10.1038/s41388-021-01922-2 · Cited by 24 · see citing works
Drakulić, D., Schwirtlich, M., Petrović, I., Mojsin, M. M., Milivojević, M., Kovačević‐Grujičić, N., & Stevanović, M. J. (2022) · Cells · doi:10.3390/cells11162530 · Cited by 24 · see citing works
Jászberényi, M., Schally, A. V., Block, N. L., Nadji, M., Vidaurre, I., Szalontay, L., & Rick, F. G. (2013) · Oncotarget · doi:10.18632/oncotarget.917 · Cited by 23 · see citing works
Atoh8 in Development and Disease
Divvela, S. S. K., Saberi, D., & Brand‐Saberi, B. (2022) · Biology · doi:10.3390/biology11010136 · Cited by 22 · see citing works
Wu, Y.-J., Richard, J.-P., Wang, S. D., Rath, P., Laterra, J., & Xia, S. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02260.x · Cited by 22 · see citing works
Self-citationXue, Y., Fu, Y., Zhao, F., Gui, G., Li, Y., Rivero-Hinojosa, S., Liu, G., Li, Y.-Q., Xia, S., Eberhart, C. G., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0603 · Cited by 20 · see citing works
Self-citationZhou, M., Yang, J., Ma, T., Feng, G., Wang, X., Wang, L., Ge, Y., Gao, R., Liu, H., Shan, L., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00957-7 · Cited by 20 · see citing works
Zhang, L., Zhao, Y., Chen, Y., Bie, C., Liang, Y., He, X., & Song, X. (2019) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2019.10.01 · Cited by 19 · see citing works
CNTF receptor subunit α as a marker for glioma tumor-initiating cells and tumor grade
Lu, J., Ksendzovsky, A., Yang, C., Mehta, G. U., Yong, R. L. M., Weil, R. J., Park, D. M., Mushlin, H. M., Fang, X., Balgley, B. M., et al. (2012) · Journal of neurosurgery · doi:10.3171/2012.9.jns1212 · Cited by 20 · see citing works
Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1
Schaefer, T., Ramadoss, A., Leu, S., Tintignac, L. A. J., Tostado, C., Bink, A., Schürch, C., Müller, J. S., Schärer, J., Moffa, G., et al. (2018) · Brain Pathology · doi:10.1111/bpa.12670 · Cited by 19 · see citing works
Daily Lifestyle Modifications to Improve Quality of Life and Survival in Glioblastoma: A Review
Travers, S. S., & Litofsky, N. S. (2021) · Brain Sciences · doi:10.3390/brainsci11050533 · Cited by 19 · see citing works
Mulcahy, E. Q. X., Zhang, Y., Colόn, R. R., Cain, S. R., Gibert, M. K., Dube, C., Hafner, M., & Abounader, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073930 · Cited by 19 · see citing works
- Authors
- Ying, M., Wang, S., Sang, Y., Sun, P., Lal, B., Goodwin, C. R., Guerrero-Cazares, H., Quinones-Hinojosa, A., Laterra, J., & Xia, S.
- Affiliations
- Kennedy Krieger Institute (US)
- Corresponding author
- Xia, S
- Venue
- Oncogene
- Published
- 2011-03-07
- Volume
- 30
- Issue
- 31
- Pages
- 3454-3467
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- PMC
- PMC3955956
- OpenAlex
- W2105823026
- Cited by
- 204
- References
- 55
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 11 · 2023: 14 · 2022: 12 · 2021: 18 · 2020: 12 · 2019: 13 · 2018: 14 · 2017: 13 · 2016: 15 · 2015: 15 · 2014: 17 · 2013: 14 · 2012: 20
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Foundation for the National Institutes of Health
- Howard Hughes Medical Institute
- James S. McDonnell Foundation
- National Institute of Neurological Disorders and Stroke (R01NS043987)
- Topics
- Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- glioblastoma stem cells, all-trans retinoic acid, Notch signaling, cancer stem cell differentiation, neurospheres, cyclin D1, p27, Notch intracellular domain, cancer stem cells, retinoid signaling, cell cycle arrest
- MeSH terms
- AC133 Antigen, Animals, Antineoplastic Agents, Brain Neoplasms, Cell Differentiation, Female, Glial Fibrillary Acidic Protein, Glioblastoma, Glycoproteins, Humans, Intermediate Filament Proteins, Mice, Nude, Nerve Tissue Proteins, Peptides, Tretinoin, Tubulin, Neoplastic Stem Cells, Antigens, CD, Gene Expression Regulation, Neoplastic, RNA-Binding Proteins, Proliferating Cell Nuclear Antigen, Cyclin D1, Gene Expression Profiling, Cell Line, Tumor, Mice, Receptors, Notch, SOXB1 Transcription Factors, Nestin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review